Trials / Conditions / Biochemically Recurrent Prostate Carcinoma

Biochemically Recurrent Prostate Carcinoma

17 registered clinical trials studyying Biochemically Recurrent Prostate Carcinoma — 6 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Evaluating In Home Cancer Therapy Versus In Clinic Cancer Therapy in Black Men With Locally Advanced, Biochemi NCT07073794	Mayo Clinic	Phase 2
Recruiting	An Investigational Scan (rhPSMA-7.3 PET/CT) for Detecting Biochemically Recurrent Prostate Cancer, ENLIGHTEN T NCT06813898	Northwestern University	EARLY_Phase 1
Recruiting	Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen NCT06378866	Mayo Clinic	Phase 2
Recruiting	SBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate Adenocarcino NCT06205316	Mayo Clinic	Phase 3
Active Not Recruiting	Radioligand Therapy After PSMA PET Guided External Beam Radiotherapy for Treating Post-Prostatectomy Patients NCT06105918	Emory University	Phase 1
Terminated	Characterization of Circulating Tumor Cells (CTCs) in High Risk and Early Metastatic Prostate Cancer Patients NCT05437679	Angle plc	—
Active Not Recruiting	RElugolix VErsus LeUprolide Cardiac Trial NCT05320406	Emory University	Phase 2
Completed	An Investigational Scan (rh PSMA 7.3 PET/MRI) for the Detection of Recurrent Disease and Aid in Radiotherapy P NCT04978675	M.D. Anderson Cancer Center	Phase 1
Terminated	68Ga-PSMA-11 PET/CT for the Diagnosis of Bone Metastases in Patients With Prostate Cancer and Biochemical Prog NCT04928820	Jonsson Comprehensive Cancer Center	Phase 2
Active Not Recruiting	An Investigational Scan (68Ga-PSMA-11 PET) for the Imaging of Prostate Cancer NCT04777071	University of Washington	Phase 2
Terminated	Durvalumab and Olaparib for the Treatment of Prostate Cancer in Men Predicted to Have a High Neoantigen Load NCT04336943	University of Washington	Phase 2
Withdrawn	Androgen Deprivation Therapy and Apalutamide With or Without Radiation Therapy for the Treatment of Biochemica NCT04585932	M.D. Anderson Cancer Center	Phase 2
Recruiting	Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET NCT04423211	ECOG-ACRIN Cancer Research Group	Phase 3
Completed	Technology-Enhanced Acceleration of Germline Evaluation for Therapy, TARGET Study NCT04447703	Thomas Jefferson University	N/A
Recruiting	Modifying Metabolic Syndrome and Cardiovascular Risk for Prostate Cancer Patients on ADT Using a Risk Factor M NCT05054296	M.D. Anderson Cancer Center	Phase 2
Completed	68Ga-PSMA-11 PET for the Diagnosis of Biochemically Recurrent Prostate Cancer NCT04216134	City of Hope Medical Center	Phase 1
Completed	68GA-PSMA-11 PET/CT Scan in Impacting Treatment Strategies for Patients With Prostate Cancer NCT04050215	Jonsson Comprehensive Cancer Center	Phase 2